2ND LINE HORMONAL-THERAPY WITH AMINOGLUTETHIMIDE IN METASTATIC BREAST-CANCER

被引：10

作者：

BRUFMAN, G

BIRAN, S

机构：

[1] Department of Clinical Oncology, Hadassah University Hospital, Jerusalem

来源：

ACTA ONCOLOGICA | 1990年 / 29卷 / 06期

关键词：

Aminoglutethimide; Breast cancer; Tamoxifen;

D O I：

10.3109/02841869009092989

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

One hundred and twenty patients with metastatic breast cancer, whose disease progressed on hormonal therapy with tamoxifen, were treated with aminoglutethimide. The overall response rate was 34% and the median duration of response 9.5 months. Response to aminoglutethimide was achieved in all metastatic sites except lung and brain. Even 25% of patients who had failed to respond to prior tamoxifen did respond objectively to aminoglutethimide. The actuarial survival for all patients at 30 months was 22% Although initial toxicity was high (70% side effects of aminoglutethimide were transient, and treatment had to be discontinued in only four patients. The results of this trial confirm that aminoglutethimide is an effective treatment in metastatic breast cancer. ©1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.

引用

页码：717 / 720

页数：4

共 50 条

[41] Hormonal therapy for postmenopausal breast cancer: the science of sequencing [J].

William R. Miller ;

John M. S. Bartlett ;

Peter Canney ;

Mark Verrill .

Breast Cancer Research and Treatment, 2007, 103 :149-160

[42] Oophorectomy as a Hormonal Ablation Therapy in Metastatic and Recurrent Breast Cancer: Current Indications and Results [J].

Islam H. Metwally ;

Omar Hamdy ;

Saleh S. Elbalka ;

Mohamed Elbadrawy ;

Dina M. Elsaid .

Indian Journal of Surgical Oncology, 2019, 10 :542-546

[43] Oophorectomy as a Hormonal Ablation Therapy in Metastatic and Recurrent Breast Cancer: Current Indications and Results [J].

Metwally, Islam H. ;

Hamdy, Omar ;

Elbalka, Saleh S. ;

Elbadrawy, Mohamed ;

Elsaid, Dina M. .

INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2019, 10 (03) :542-546

[44] Menopausal Hormonal Therapy and Breast Cancer [J].

Bakhidze, E., V ;

Belyaeva, A., V ;

Berlev, I., V ;

Anisimov, V. N. ;

Belyaev, A. M. .

ADVANCES IN GERONTOLOGY, 2021, 11 (04) :382-390

[45] Hormonal replacement therapy and breast cancer [J].

Noël, G ;

Feuvret, L ;

Gasowski, M ;

Bernard, A ;

Cappelaere, P .

BULLETIN DU CANCER, 1998, 85 (12) :997-1014

[46] The role of hormonal therapy in breast cancer [J].

Noguchi M. ;

Miwa K. .

Breast Cancer, 1998, 5 (1) :33-46

[47] Breast cancer and hormonal replacement therapy [J].

Vassilopoulou-Sellin, R .

WOMEN'S HEALTH AND DISEASE: GYNECOLOGIC AND REPRODUCTIVE ISSUES, 2003, 997 :341-350

[48] Menopausal Hormonal Therapy and Breast Cancer [J].

E. V. Bakhidze ;

A. V. Belyaeva ;

I. V. Berlev ;

V. N. Anisimov ;

A. M. Belyaev .

Advances in Gerontology, 2021, 11 :382-390

[49] PIRARUBICIN IN COMBINATION CHEMOTHERAPY FOR METASTATIC BREAST-CANCER [J].

HORTOBAGYI, GN ;

THERIAULT, RL ;

FRYE, D ;

WALTERS, RS ;

FRASCHINI, G ;

TASHIMA, CK ;

RO, JS ;

SALEWSKI, E ;

BUZDAR, AU .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 :S54-S56

[50] NEW DEVELOPMENTS IN CHEMOTHERAPY FOR METASTATIC BREAST-CANCER [J].

VANDENBERG, TA .

ANTI-CANCER DRUGS, 1994, 5 (03) :251-259

← 1 2 3 4 5 →